Stocks · US
BAX
XNYS
Baxter International Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B2.02x
P/S1.09x
EPS$-1.95
ROE-16.21%
ROA-5.08%
Dividend yield1.47%
EV/EBITDA18.89x
Debt/Equity1.52
Free cash flow$815M
Returns and 52-week range
1W+3.75%
1M-5.69%
3M+10.83%
6M+46.57%
1Y+2.10%
YTD+24.92%
52W high$30.00
52W low$15.73
From 52W high-18.80%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 10X 지노믹스 | $12.7B | — | 15.43 | +28.75% |
| 페넘브라 | $12.5B | 77.78 | 8.16 | -1.59% |
| BridgeBio Pharma, Inc. Common Stock | $12.9B | — | — | -10.53% |
| Halozyme Therapeutics, Inc. | $12.3B | 29.72 | 85.64 | -0.43% |
| Icon Plc | $13.0B | 38.45 | 6.71 | -1.92% |
| BrightSpring Health Services, Inc. Common Stock | $12.3B | 33.52 | 5.99 | +4.97% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.